CollPlant Biotechnologies (CLGN) Liabilities and Shareholders Equity (2017 - 2026)
CollPlant Biotechnologies' Liabilities and Shareholders Equity was $10.79 million in the quarter ended Dec 31, 2025, down 42.4% from $18.71 million a year earlier and down 23.5% from the prior quarter.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
From the quarter ended Dec 31, 2017 onward, CollPlant Biotechnologies has reported Liabilities and Shareholders Equity for 32 quarters.
- Liabilities and Shareholders Equity has now declined for four consecutive years, with a five-year compound annual growth rate of -0.1% (years ended Dec 2020 to Dec 2025).
- In earlier years, Liabilities and Shareholders Equity was $18.71 million in the year ended Dec 31, 2024 (-45.2%), $34.13 million in the year ended Dec 31, 2023 (-9.6%), $37.77 million in the year ended Dec 31, 2022 (-26.3%) and $51.22 million in the year ended Dec 31, 2021 (+372.5%).
- The figure for the quarter ended Dec 31, 2025 marks the lowest quarterly Liabilities and Shareholders Equity since the quarter ended Dec 31, 2019.
- Compared with a year earlier, Liabilities and Shareholders Equity has declined for three straight quarters, with an average decline of 35.8% over the last seven quarters.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was the quarter ended Jun 30, 2021 (growth of 402.6%); the worst was the quarter ended Dec 31, 2024 (a decline of 45.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | CollPlant Biotechnologies | 4.74 Mn | -24.70 Mn | -456,000.00 | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.20 Mn |
| Dec 31, 2025 | 10.79 Mn |
| Sep 30, 2025 | 14.09 Mn |
| Jun 30, 2025 | 17.44 Mn |
| Dec 31, 2024 | 18.71 Mn |
| Sep 30, 2024 | 22.44 Mn |
| Jun 30, 2024 | 26.57 Mn |
| Mar 31, 2024 | 30.29 Mn |
| Dec 31, 2023 | 34.13 Mn |
| Sep 30, 2023 | 37.56 Mn |
| Jun 30, 2023 | 41.57 Mn |
| Mar 31, 2023 | 35.76 Mn |
| Dec 31, 2022 | 37.77 Mn |
| Sep 30, 2022 | 40.56 Mn |
| Jun 30, 2022 | 44.41 Mn |
| Mar 31, 2022 | 48.72 Mn |
| Dec 31, 2021 | 51.22 Mn |
| Sep 30, 2021 | 53.63 Mn |
| Jun 30, 2021 | 55.02 Mn |
| Mar 31, 2021 | 56.63 Mn |
API Access
CollPlant Biotechnologies Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();